Biomaterials.info

powered by FreeFind

US Food and Drug Administration (FDA) - Inactive Ingredients

FDA Inactive Ingredients - Updated May 2006

What is the purpose of the Inactive Ingredients Database?

The Inactive Ingredients Database provides information on inactive ingredients present in FDA-approved drug products. This information can be used by industry as an aid in developing drug products. For new drug development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route of administration, the inactive ingredient is not considered new and may require a less extensive review the next time it is included in a new drug product. For example, if a particular inactive ingredient has been approved in a certain dosage form at a certain potency, a sponsor could consider it safe for use in a similar manner for a similar type of product.
FDA Devices
FDA Inactive Ingredients
FDA Inactive Ingredients
FDA Inactive Ingredients


First Page Previous Page Next Page Last Page
Inactive Ingredient Route / Dosage Form
PETROLATUM, WHITE DENTAL; PASTE
PETROLATUM, WHITE NASAL; OINTMENT
PETROLATUM, WHITE OPHTHALMIC; OINTMENT
PETROLATUM, WHITE TOPICAL; CREAM, AUGMENTED
PETROLATUM, WHITE TOPICAL; EMULSION, CREAM
PETROLATUM, WHITE TOPICAL; LOTION
PETROLATUM, WHITE TOPICAL; OINTMENT
PETROLATUM, WHITE TOPICAL; OINTMENT, AUGMENTED
PETROLATUM, WHITE TRANSDERMAL; OINTMENT
PETROLATUM, WHITE VAGINAL; OINTMENT
PETROLEUM DISTILLATES TOPICAL; EMULSION, CREAM
PHARMABURST B1 ORAL; TABLET, ORALLY DISINTEGRATING
PHARMABURST B2 ORAL; TABLET, ORALLY DISINTEGRATING
PHARMACEUTICAL GLAZE ORAL; CAPSULE
PHARMACEUTICAL GLAZE ORAL; CAPSULE, COATED PELLETS
PHARMACEUTICAL GLAZE ORAL; CAPSULE, SUSTAINED ACTION
PHARMACEUTICAL GLAZE ORAL; TABLET
PHARMACEUTICAL GLAZE ORAL; TABLET, COATED
PHARMACEUTICAL GLAZE ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
PHARMACEUTICAL GLAZE ORAL; TABLET, FILM COATED
PHARMACEUTICAL GLAZE ORAL; TABLET, SUSTAINED ACTION
PHARMACEUTICAL GLAZE ORAL; TABLET, SUSTAINED ACTION, COATED
PHARMACOAT 606 ORAL; TABLET
PHARMACOAT 606 ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
PHARMATOSE DCL II ORAL; TABLET
PHENETHYL ALCOHOL AURICULAR (OTIC); SOLUTION
PHENETHYL ALCOHOL NASAL; SOLUTION
PHENETHYL ALCOHOL NASAL; SPRAY, METERED
PHENETHYL ALCOHOL OPHTHALMIC; SOLUTION
PHENETHYL ALCOHOL OPHTHALMIC; SUSPENSION
PHENOL IM - IV - SC; INJECTION
PHENOL IM - IV; INJECTION
PHENOL IM - SC; INJECTION
PHENOL IM - SC; INJECTION, SUSTAINED ACTION
PHENOL INTRA-ARTICULAR; INJECTION
PHENOL INTRADERMAL; INJECTION
PHENOL INTRALESIONAL; INJECTION
PHENOL INTRAMUSCULAR; INJECTABLE
PHENOL INTRAMUSCULAR; INJECTION
PHENOL INTRAMUSCULAR; INJECTION, SUSTAINED ACTION
PHENOL INTRAMUSCULAR; POWDER, FOR INJECTION SOLUTION
PHENOL INTRAMUSCULAR; SOLUTION, INJECTION
PHENOL INTRASYNOVIAL; INJECTION
PHENOL INTRAVENOUS; INJECTABLE
PHENOL INTRAVENOUS; INJECTION
PHENOL IV - SC; INJECTION
PHENOL IV(INFUSION); INJECTION
PHENOL SOFT TISSUE; INJECTION
PHENOL SUBCUTANEOUS; INJECTABLE
PHENOL SUBCUTANEOUS; INJECTION
PHENOL SUBCUTANEOUS; SOLUTION, INJECTION
PHENOL SUBCUTANEOUS; SUSPENSION, INJECTION
PHENOL, LIQUEFIED IM - IV; INJECTION
PHENOL, LIQUEFIED IM - SC; INJECTION
PHENOL, LIQUEFIED IV - SC; LIQUID
PHENOL, LIQUEFIED SUBCUTANEOUS; INJECTION
PHENOL, LIQUEFIED SUBCUTANEOUS; SUSPENSION, INJECTION
PHENONIP TRANSDERMAL; PATCH, CONTROLLED RELEASE
PHENOXYETHANOL TOPICAL; CREAM, AUGMENTED
PHENOXYETHANOL TOPICAL; EMULSION, CREAM
PHENOXYETHANOL TOPICAL; GEL
PHENYLALANINE IV(INFUSION); INJECTION
PHENYLALANINE IV(INFUSION); SOLUTION, INJECTION
PHENYLALANINE ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
PHENYLMERCURIC ACETATE OPHTHALMIC; OINTMENT
PHENYLMERCURIC ACETATE TOPICAL; EMULSION, CREAM
PHENYLMERCURIC ACETATE VAGINAL; EMULSION, CREAM
PHENYLMERCURIC NITRATE INTRAMUSCULAR; POWDER, FOR INJECTION SOLUTION
PHENYLMERCURIC NITRATE OPHTHALMIC; OINTMENT
PHENYLMERCURIC NITRATE OPHTHALMIC; SOLUTION
PHOSPHATIDYL GLYCEROL, EGG INTRAVENOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
PHOSPHOLIPID IV(INFUSION); EMULSION, INJECTION
PHOSPHOLIPID IV(INFUSION); INJECTION
PHOSPHOLIPID, EGG IV(INFUSION); INJECTION
PHOSPHOLIPON 90G VAGINAL; EMULSION, CREAM
PHOSPHORIC ACID IM - IV - SC; INJECTION
PHOSPHORIC ACID IM - IV; INJECTION
PHOSPHORIC ACID IM - SC; INJECTION
PHOSPHORIC ACID IM - SC; POWDER, FOR INJECTION SOLUTION
PHOSPHORIC ACID INTRA-ARTICULAR; INJECTION
PHOSPHORIC ACID INTRALESIONAL; INJECTION
PHOSPHORIC ACID INTRAMUSCULAR; POWDER, FOR INJECTION SOLUTION
PHOSPHORIC ACID INTRAMUSCULAR; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
PHOSPHORIC ACID INTRAVENOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
PHOSPHORIC ACID INTRAVENOUS; SOLUTION
PHOSPHORIC ACID IV - SC; INJECTION
PHOSPHORIC ACID IV(INFUSION); INJECTION
PHOSPHORIC ACID IV(INFUSION); POWDER, FOR INJECTION SOLUTION
PHOSPHORIC ACID IV(INFUSION); SOLUTION, INJECTION
PHOSPHORIC ACID OPHTHALMIC; SOLUTION, DROPS
PHOSPHORIC ACID ORAL; SOLUTION
PHOSPHORIC ACID ORAL; TABLET
PHOSPHORIC ACID ORAL; TABLET, CONTROLLED RELEASE
PHOSPHORIC ACID ORAL; TABLET, EXTENDED RELEASE
PHOSPHORIC ACID ORAL; TABLET, SUSTAINED ACTION, FILM COATED
PHOSPHORIC ACID SOFT TISSUE; INJECTION
PHOSPHORIC ACID SUBCUTANEOUS; INJECTION
PHOSPHORIC ACID SUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION
PHOSPHORIC ACID SUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
PHOSPHORIC ACID SUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES

First Page Previous Page Next Page Last Page




Last Modified: 29 April 2006
http://www.biomaterials.info
Sitemap
Link | Link | Link | Link | Link | Link | Link | Link